In Silico assigned resistance genes confer Bifidobacterium with partial resistance to aminoglycosides but not to ?-lactams

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Fouhy, Fiona ^a,b   O'Connell Motherway, Mary ^b,c   Fitzgerald, Gerald F ^b,c   Ross, R Paul ^a,c   Stanton, Catherine ^a,c   Van Sinderen, Douwe ^b,c   Cotter, Paul D ^a,c  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; GENTAMICIN; KANAMYCIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM MUTANT; BBR 0651 GENE; BBR 1586 GENE; BIFIDOBACTERIUM BREVE; COMPUTER MODEL; CONTROLLED STUDY; GENE DISRUPTION; GENE INACTIVATION; GENE INSERTION; GENE TARGETING; GENETIC CODE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; UNINDEXED SEQUENCE; WILD TYPE;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; BIFIDOBACTERIUM; DATABASES, PROTEIN; DRUG RESISTANCE, BACTERIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 84891921975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082653     Document Type: Article

References (69)

1. Fleming A (1979) On the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. British Journal of Experimental Pathology 60: 3-16.
2. Davies J, Davies D (2010) Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74: 417-433. doi:10.1128/MMBR. 00016-10. PubMed: 20805405.
3. Bush K (2012) Improving known classes of antibiotics: an optimistic approach for the future. Curr Opin Pharmacol 12: 527-534. doi: 10.1016/j.coph.2012.06.003. PubMed: 22748801.
4. Walsh C (2000) Molecular mechanisms that confer antibacterial drug resistance. Nature 406: 775-781. doi:10.1038/35021219. PubMed: 10963607.
5. Mingeot-Leclercq MP, Glupczynski Y, Tulkens PM (1999) Aminoglycosides: activity and resistance. Antimicrob Agents Chemother 43: 727-737. PubMed: 10103173. (Pubitemid 29165732)
6. Jacoby G, Gorini L (1967) The effect of streptomycin and other aminoglycoside antibiotics on protein synthesis. Mechanism of Action: Springer. pp. 726-747.
7. Davies J, Wright GD (1997) Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol 5: 234-240. doi:10.1016/S0966-842X(97)01033-0. PubMed: 9211644. (Pubitemid 27348681)
8. Shaw KJ, Rather PN, Hare RS, Miller GH (1993) Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57: 138-163. PubMed: 8385262. (Pubitemid 23078440)
9. Kotra LP, Mobashery S (1998) β-Lactam antibiotics, β-lactamases and bacterial resistance. Bulletin de l'Institut Pasteur 96: 139-150. doi: 10.1016/S0020-2452(98)80009-2. (Pubitemid 28396302)
10. Page MGP (2012) Beta-Lactam Antibiotics. Antibiotic Discovery and Development: 79-117. doi:10.1007/978-1-4614-1400-1-3.
11. Tipper D (1979) Mode of action of β-lactam antibiotics. Reviews of Infectious Diseases 1: 39-53. doi:10.1093/clinids/1.1.39.
12. Tipper DJ, Strominger JL (1965) Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. Proc Natl Acad Sci U S A 54: 1133-1141. doi:10.1073/pnas.54.4.1133. PubMed: 5219821.
13. Georgopapadakou NH (1993) Penicillin-binding proteins and bacterial resistance to beta-lactams. Antimicrob Agents Chemother 37: 2045-2053. doi:10.1128/AAC.37.10.2045. PubMed: 8257121. (Pubitemid 23298187)
14. Pitout JD, Sanders CC, Sanders WE Jr (1997) Antimicrobial resistance with focus on beta-lactam resistance in gram-negative bacilli. Am J Med 103: 51-59. doi:10.1016/S0002-9343(97)00044-2. PubMed: 9236486. (Pubitemid 27314188)
15. Abraham E, Chain E (1940) An enzyme from bacteria able to destroy penicillin. Nature 146: 837-837. doi:10.1038/146837b0.
16. Richmond MH, Sykes RB (1973) The, B-lactamases of gram-negative bacteria and their possible physiological role. Adv Microb Physiol 9: 31-88. doi:10.1016/S0065-2911(08)60376-8. PubMed: 4581138.
17. Ambler R (1980) The Structure of beta-lactamases. Philosophical Transactions of the Royal Society of London B, Biological Sciences 289: 321-331. doi:10.1098/rstb.1980.0049.
18. Bush K (1989) Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'. Antimicrob Agents Chemother 33: 264-270. doi:10.1128/AAC. 33.3.264. PubMed: 2658780.
19. Bush K, Jacoby GA (2010) Updated functional classification of β- lactamases. Antimicrob Agents Chemother 54: 969-976. doi:10.1128/AAC.01009-09. PubMed: 19995920.
20. Bush K, Jacoby GA, Medeiros AA (1995) A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39: 1211-1233. doi:10.1128/AAC.39.6.1211. PubMed: 7574506.
21. Commission E (2008) Technical guidance prepared by the Panel on Additives and Products or Substances used in; Feed Animal Feed (FEEDAP) on the update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance. EFSA J: 1-15
22. Huys G, Botteldoorn N, Delvigne F, De Vuyst L, Heyndrickx M et al. (2013) Microbial characterization of probiotics-Advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC). Molecular Nutrition and Food Research 57: 1479-1504.
23. Vankerckhoven V, Huys G, Vancanneyt M, Vael C, Klare I et al. (2008) Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trends in Food Science and Technology 19: 102-114. doi:10.1016/j.tifs.2007.07.013.
24. Chouraqui JP, Van Egroo LD, Fichot MC (2004) Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr 38: 288-292. doi: 10.1097/00005176-200403000-00011. PubMed: 15076628.
25. He T, Priebe MG, Zhong Y, Huang C, Harmsen HJ et al. (2008) Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose-intolerant subjects. J Appl Microbiol 104: 595-604. PubMed: 17927751.
26. Wang KY, Li SN, Liu CS, Perng DS, Su YC et al. (2004) Effects of ingesting Lactobacillus-and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am J Clin Nutr 80: 737-741. PubMed: 15321816.
27. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K et al. (2003) Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci 86: 2452-2461. doi: 10.3168/jds.S0022-0302(03)73839-9. PubMed: 12906063. (Pubitemid 39001266)
28. Kailasapathy K, Chin J (2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78: 80-88. doi:10.1046/j. 1440-1711.2000.00886.x. PubMed: 10651933. (Pubitemid 30090993)
29. Kheadr E, Bernoussi N, Lacroix C, Fliss I (2004) Comparison of the sensitivity of commercial strains and infant isolates of bifidobacteria to antibiotics and bacteriocins. International Dairy Journal 14: 1041-1053. doi:10.1016/j.idairyj.2004.04.010. (Pubitemid 39239304)
30. Mayrhofer S, Mair C, Kneifel W, Domig KJ (2011) Susceptibility of Bifidobacteria of Animal Origin to Selected Antimicrobial Agents. Chemotherapy research and practice 2011. doi:10.1155/2011/989520.
31. Xiao JZ, Takahashi S, Odamaki T, Yaeshima T, Iwatsuki K (2010) Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market. Biosci Biotechnol Biochem 74: 336-342. doi:10.1271/bbb.90659. PubMed: 20139616.
32. Sato T, Iino T (2010) Genetic analyses of the antibiotic resistance of Bifidobacterium bifidumstrain Yakult YIT 4007. Int J Food Microbiol 137: 254-258. doi:10.1016/j.ijfoodmicro.2009.12.014. PubMed: 20051305.
33. Yazid AM, Ali AM, Shuhaimi M, Kalaivaani V, Rokiah MY et al. (2000) Antimicrobial susceptibility of bifidobacteria. Lett Appl Microbiol 31: 57-62. PubMed: 10886616. (Pubitemid 30458697)
34. D'Aimmo MR, Modesto M, Biavati B (2007) Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products. Int J Food Microbiol 115: 35-42. doi:10.1016/j.ijfoodmicro.2006.10. 003. PubMed: 17198739. (Pubitemid 46349309)
35. Vlková E, Rada V, Popelářová P, Trojanová I, Killer J (2006) Antimicrobial susceptibility of bifidobacteria isolated from gastrointestinal tract of calves. Livestock Science 105: 253-259. doi: 10.1016/j.livsci.2006.04.011. (Pubitemid 44646901)
36. Fouhy F, Guinane CM, Hussey S, Wall R, Ryan CA et al. (2012) Highthroughput sequencing reveals the incomplete, short-term, recovery of the infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamycin. Antimicrob Agents Chemother 56: 5811-5820. doi:10.1128/AAC. 00789-12. PubMed: 22948872.
37. Kiwaki M, Sato T (2009) Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotic B. breve strain Yakult. Int J Food Microbiol 134: 211-215. doi: 10.1016/j.ijfoodmicro.2009.06.011. PubMed: 19616336.
38. Masco L, Van Hoorde K, De Brandt E, Swings J, Huys G (2006) Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products. J Antimicrob Chemother 58: 85-94. doi: 10.1093/jac/dkl197. PubMed: 16698847. (Pubitemid 44313382)
39. Andrews JM (2009) BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 64: 454-489. doi: 10.1093/jac/dkp244. PubMed: 19587067.
40. Andrews JM (2001) The development of the BSAC standardized method of disc diffusion testing. J Antimicrob Chemother 48: 29-42. doi: 10.1093/jac/48.suppl- 1.29. PubMed: 11420335.
41. Andrews JM (2001) BSAC standardized disc susceptibility testing method. J Antimicrob Chemother 48: 43-57. doi:10.1093/jac/48.suppl-1.43. PubMed: 11420336.
42. Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48: 5-16. doi:10.1093/jac/48.suppl-1.5. PubMed: 11420333.
43. Moubareck C, Gavini F, Vaugien L, Butel MJ, Doucet-Populaire F (2005) Antimicrobial susceptibility of bifidobacteria. J Antimicrob Chemother 55: 38-44. PubMed: 15574479. (Pubitemid 40197486)
44. Lee DT, Rosenblatt JE (1983) A comparison of four methods for detecting β-lactamase in anaerobic bacteria. Diagn Microbiol Infect Dis 1: 173-175. doi:10.1016/0732-8893(83)90048-2. PubMed: 6370561.
45. O'Connell Motherway M, O'Driscoll J, Fitzgerald GF, Van Sinderen D (2009) Overcoming the restriction barrier to plasmid transformation and targeted mutagenesis in Bifidobacterium breve UCC2003. Microb Biotechnol 2: 321-332. doi:10.1111/j.1751-7915.2008.00071.x. PubMed: 21261927.
46. Mazé A, O'Connell-Motherway M, Fitzgerald GF, Deutscher J, van Sinderen D (2007) Identification and characterization of a fructose phosphotransferase system in Bifidobacterium breve UCC2003. Appl Environ Microbiol 73: 545-553. doi:10.1128/AEM.01496-06. PubMed: 17098914. (Pubitemid 46147585)
47. Álvarez-Martín P, O'Connell-Motherway M, van Sinderen D, Mayo B (2007) Functional analysis of the pBC1 replicon from Bifidobacterium catenulatum L48. Appl Microbiol Biotechnol 76: 1395-1402. doi: 10.1007/s00253-007-1115-5. PubMed: 17704917. (Pubitemid 47459785)
48. Law J, Buist G, Haandrikman A, Kok J, Venema G et al. (1995) A system to generate chromosomal mutations in Lactococcus lactis which allows fast analysis of targeted genes. J Bacteriol 177: 7011-7018. PubMed: 8522504.
49. Nishimoto M, Kitaoka M (2007) Identification of N-acetylhexosamine 1- kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum. Appl Environ Microbiol 73: 6444-6449. doi:10.1128/AEM.01425-07. PubMed: 17720833. (Pubitemid 47623702)
50. O'Connell Motherway M, Zomer A, Leahy SC, Reunanen J, Bottacini F et al. (2011) Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc Natl Acad Sci U S A 108: 11217-11222. doi:10.1073/pnas.1105380108. PubMed: 21690406.
51. O'Connell Motherway M, Kinsella M, Fitzgerald GF, Sinderen D (2013) Transcriptional and functional characterization of genetic elements involved in galacto-oligosaccharide utilization by Bifidobacterium breve UCC2003. Microb Biotechnol 6: 67-79. doi:10.1111/1751-7915.12011. PubMed: 23199239.
52. O'Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7: 688-693. doi:10.1038/sj.embor.7400731. PubMed: 16819463. (Pubitemid 43986264)
53. Salyers AA, Gupta A, Wang Y (2004) Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol 12: 412-416. doi:10.1016/j.tim.2004.07.004. PubMed: 15337162. (Pubitemid 39178592)
54. Sommer MOA, Dantas G, Church GM (2009) Functional characterization of the antibiotic resistance reservoir in the human microflora. Science 325: 1128-1131. doi:10.1126/science.1176950. PubMed: 19713526.
55. Fallani M, Young D, Scott J, Norin E, Amarri S et al. (2010) Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breast-feeding, and antibiotics. J Pediatr Gastroenterol Nutr 51: 77-84. doi:10.1097/MPG.0b013e3181d1b11e. PubMed: 20479681.
56. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O et al. (2010) Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59: 1635-1642. doi:10.1136/gut.2010.215665. PubMed: 20926643.
57. Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG et al. (2007) Selective increases of bifidobacteria in gut microflora improve high-fatdiet- induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50: 2374-2383. doi:10.1007/s00125-007-0791-0. PubMed: 17823788. (Pubitemid 47512397)
58. Mitsuoka T (1990) Bifidobacteria and their role in human health. Journal of Industrial Microbiology 6: 263-267. doi:10.1007/BF01575871.
59. Ventura M, Turroni F, Zomer A, Foroni E, Giubellini V et al. (2009) The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity. PLoS Genet 5: e1000785. PubMed: 20041198.
60. Lim KS, Huh CS, Baek YJ (1993) Antimicrobial susceptibility of bifidobacteria. J Dairy Sci 76: 2168-2174. doi:10.3168/jds.S0022-0302(93)77553- 0. PubMed: 8408866.
61. Jones BV, Begley M, Hill C, Gahan CG, Marchesi JR (2008) Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci U S A 105: 13580-13585. doi:10.1073/pnas. 0804437105. PubMed: 18757757.
62. Lambert JM, Bongers RS, de Vos WM, Kleerebezem M (2008) Functional analysis of four bile salt hydrolase and penicillin acylase family members in Lactobacillus plantarum WCFS1. Appl Environ Microbiol 74: 4719-4726. doi:10.1128/AEM.00137-08. PubMed: 18539794.
63. Schnoes AM, Brown SD, Dodevski I, Babbitt PC (2009) Annotation error in public databases: misannotation of molecular function in enzyme superfamilies. PLoS Comput Biol 5: e1000605. PubMed: 20011109.
64. Andorf C, Dobbs D, Honavar V (2007) Exploring inconsistencies in genome-wide protein function annotations: a machine learning approach. Bmc Bioinformatics 8: 284-296. doi: 10.1186/1471-2105-8-284. PubMed: 17683567.
65. Brenner SE (1999) Errors in genome annotation. Trends Genet 15: 132-133. doi:10.1016/S0168-9525(99)01706-0. PubMed: 10203816. (Pubitemid 29155430)
66. Devos D, Valencia A (2001) Intrinsic errors in genome annotation. Trends Genet 17: 429-431. doi:10.1016/S0168-9525(01)02348-4. PubMed: 11485799. (Pubitemid 32727226)
67. Jones CE, Brown AL, Baumann U (2007) Estimating the annotation error rate of curated GO database sequence annotations. Bmc Bioinformatics 8: 170-179. doi:10.1186/1471-2105-8-170. PubMed: 17519041.
68. Bryan LE, Kowand SK, Van Den Elzen HM (1979) Mechanism of aminoglycoside antibiotic resistance in anaerobic bacteria: Clostridium perfringens and Bacteroides fragilis. Antimicrob Agents Chemother 15: 7-13. doi:10.1128/AAC.15. 1.7. PubMed: 218500. (Pubitemid 9099624)
69. Talwalkar A, Kailasapathy K (2004) The role of oxygen in the viability of probiotic bacteria with reference to L. acidophilus and Bifidobacterium spp. Curr Issues Intest Microbiol 5: 1-8. PubMed: 15055922. (Pubitemid 38372210)